Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease
We developed a novel quantification method named shape feature using F-18 florapronol positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/12/1/132 |
| _version_ | 1797494711978557440 |
|---|---|
| author | Do-Hoon Kim Junik Son Chae Moon Hong Ho-Sung Ryu Shin Young Jeong Sang-Woo Lee Jaetae Lee |
| author_facet | Do-Hoon Kim Junik Son Chae Moon Hong Ho-Sung Ryu Shin Young Jeong Sang-Woo Lee Jaetae Lee |
| author_sort | Do-Hoon Kim |
| collection | DOAJ |
| description | We developed a novel quantification method named shape feature using F-18 florapronol positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment or other precursors dementia (non-AD). We calculated the cerebral amyloid smoothing score (CASS) and brain atrophy index (BAI) using the surface area and volume of the region of interest in PET images. We calculated gray and white matter from trained CT data, prepared using U-net. Shape feature was calculated by multiplying CASS with BAI scores. We measured region-based standard uptake values (SUVr) and performed receiver operating characteristic (ROC) analysis to compare SUVr, shape feature, CASS, and BAI score. We investigated the relationship between shape feature and neuropsychological tests. Fifty subjects (23 with AD and 27 with non-AD) were evaluated. SUVr, shape feature, CASS, and BAI score were significantly higher in patients with AD than in those with non-AD. There was no statistically significant difference between shape feature and SUVr in ROC analysis. Shape feature correlated well with mini-mental state examination scores. Shape feature can effectively quantify beta-amyloid deposition and atrophic changes in the brain. These results suggest that shape feature is useful in the diagnosis of AD. |
| first_indexed | 2024-03-10T01:38:17Z |
| format | Article |
| id | doaj.art-4484125e0bda4c8b9bfa369706c81121 |
| institution | Directory Open Access Journal |
| issn | 2075-4418 |
| language | English |
| last_indexed | 2024-03-10T01:38:17Z |
| publishDate | 2022-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Diagnostics |
| spelling | doaj.art-4484125e0bda4c8b9bfa369706c811212023-11-23T13:28:49ZengMDPI AGDiagnostics2075-44182022-01-0112113210.3390/diagnostics12010132Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s DiseaseDo-Hoon Kim0Junik Son1Chae Moon Hong2Ho-Sung Ryu3Shin Young Jeong4Sang-Woo Lee5Jaetae Lee6Department of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Neurology, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaDepartment of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, Daegu 41944, KoreaWe developed a novel quantification method named shape feature using F-18 florapronol positron emission tomography–computed tomography (PET/CT) and evaluated its sensitivity and specificity for discriminating between patients with Alzheimer’s disease (AD) and patients with mild cognitive impairment or other precursors dementia (non-AD). We calculated the cerebral amyloid smoothing score (CASS) and brain atrophy index (BAI) using the surface area and volume of the region of interest in PET images. We calculated gray and white matter from trained CT data, prepared using U-net. Shape feature was calculated by multiplying CASS with BAI scores. We measured region-based standard uptake values (SUVr) and performed receiver operating characteristic (ROC) analysis to compare SUVr, shape feature, CASS, and BAI score. We investigated the relationship between shape feature and neuropsychological tests. Fifty subjects (23 with AD and 27 with non-AD) were evaluated. SUVr, shape feature, CASS, and BAI score were significantly higher in patients with AD than in those with non-AD. There was no statistically significant difference between shape feature and SUVr in ROC analysis. Shape feature correlated well with mini-mental state examination scores. Shape feature can effectively quantify beta-amyloid deposition and atrophic changes in the brain. These results suggest that shape feature is useful in the diagnosis of AD.https://www.mdpi.com/2075-4418/12/1/132beta-amyloidpositron emission tomographyF-18 florapronolAlzheimer’s diseasecerebral amyloid smoothing scorebrain atrophy index |
| spellingShingle | Do-Hoon Kim Junik Son Chae Moon Hong Ho-Sung Ryu Shin Young Jeong Sang-Woo Lee Jaetae Lee Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease Diagnostics beta-amyloid positron emission tomography F-18 florapronol Alzheimer’s disease cerebral amyloid smoothing score brain atrophy index |
| title | Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease |
| title_full | Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease |
| title_fullStr | Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease |
| title_full_unstemmed | Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease |
| title_short | Simple Quantification of Surface Uptake in F-18 Florapronol PET/CT Imaging for the Validation of Alzheimer’s Disease |
| title_sort | simple quantification of surface uptake in f 18 florapronol pet ct imaging for the validation of alzheimer s disease |
| topic | beta-amyloid positron emission tomography F-18 florapronol Alzheimer’s disease cerebral amyloid smoothing score brain atrophy index |
| url | https://www.mdpi.com/2075-4418/12/1/132 |
| work_keys_str_mv | AT dohoonkim simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT junikson simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT chaemoonhong simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT hosungryu simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT shinyoungjeong simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT sangwoolee simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease AT jaetaelee simplequantificationofsurfaceuptakeinf18florapronolpetctimagingforthevalidationofalzheimersdisease |